Indeed, mutations that abrogate expression of dystrophin or impair binding of α-dystroglycan to the extracellular matrix lead to usually severe forms of muscular dystrophy associated with myofiber degeneration [9–14]. This evidence concerns the gene DAG1 and muscular dystrophy.